Dr. Hitto Kaufmann of Sanofi-Aventis and Dr. Eliana Clark of Biogen to Deliver Plenary Keynote Presentations at CHI's Bioprocessing Summit Europe

Needham, MA, USA, December 12, 2017 / B3C newswire / -- Cambridge Healthtech Institute, a division of Cambridge Innovation Institute, is pleased to announce that Dr. Hitto Kaufmann, Global Vice President, Biopharmaceuticals Development and Platform Process Development, Sanofi-Aventis and Dr. Eliana Clark, Vice President, International Manufacturing Operations, Biogen will be the plenary keynote speakers at the Inaugural Bioprocessing Summit Europe, taking place 20-22 March 2018 in Lisbon. These presentations will explore next-gen bioprocess strategies, pipelines and facilities. An impressive group of over fifty distinguished speakers will join Dr. Kaufmann and Dr. Clark in sharing their knowledge, best practices, and expertise with all attendees.

“The Bioprocessing Summit Europe is the perfect venue for upstream and downstream professionals to find practical solutions for today’s bioproduction needs,” states Dan Barry, Cambridge Healthtech Institute's Senior Conference Director.  “We are thrilled with response so far and very excited to see exclusive keynote speakers from Biogen, Sanofi, Boehringer Ingelheim and BOKU.”

Created by the producers of PEGS, PepTalk and The Bioprocessing Summit Boston, this four-conference, scientifically driven meeting is packed with the latest science, technology updates, and best practice in cell culture, scale-up, recovery, purification, continuous manufacturing, process intensification and bioproduction.

Full program details can be found at http://bioprocessingeurope.com/.

Members of the media are encouraged to attend. Please contact Lisa Scimemi at lscimemi@healthtech.com to apply for a press pass.